Gisela Paulsen - Net Worth and Insider Trading

Gisela Paulsen Net Worth

The estimated net worth of Gisela Paulsen is at least $5,848 dollars as of 2023-04-01. Gisela Paulsen is the COO of OncoCyte Corp and owns about 16,500 shares of OncoCyte Corp (OCX) stock worth over $5,848. Details can be seen in Gisela Paulsen's Latest Holdings Summary section.

Transaction Summary of Gisela Paulsen


Gisela Paulsen Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Gisela Paulsen owns 2 companies in total, including Exact Sciences Corp (EXAS) , and OncoCyte Corp (OCX) .

Click here to see the complete history of Gisela Paulsen’s form 4 insider trades.

Insider Ownership Summary of Gisela Paulsen

Ticker Comapny Transaction Date Type of Owner
EXAS Exact Sciences Corp 2020-04-20 Gen Mgr & Precision Oncology
OCX OncoCyte Corp 2021-10-04 Chief Operating Officer

Gisela Paulsen Latest Holdings Summary

Gisela Paulsen currently owns a total of 1 stock. Gisela Paulsen owns 16,500 shares of OncoCyte Corp (OCX) as of March 17, 2022, with a value of $5,848.

Latest Holdings of Gisela Paulsen

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
OCX OncoCyte Corp 2022-03-17 16,500 0.35 5,848

Holding Weightings of Gisela Paulsen

Gisela Paulsen Form 4 Trading Tracker

According to the SEC Form 4 filings, Gisela Paulsen has made a total of 1 transactions in OncoCyte Corp (OCX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in OncoCyte Corp is the acquisition of 16,500 shares on March 17, 2022, which cost Gisela Paulsen around $19,800.

Insider Trading History of Gisela Paulsen

Insider Trading Shares
Shares Change
Final Share
Current Price
Price Change Since Insider Trade (%)
Filing Date
OncoCyte Corp
Total 1
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Gisela Paulsen Trading Performance

GuruFocus tracks the stock performance after each of Gisela Paulsen's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Gisela Paulsen is -28%. GuruFocus also compares Gisela Paulsen's trading performance to market benchmark return within the same time period. The performance of stocks bought by Gisela Paulsen within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Gisela Paulsen's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Gisela Paulsen

Average Relative Return

Outperforming Transactions

Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Relative Return(%) -5.97 -28 -33.58 -80.07
Relative Return to S&P 500(%) -5.54 -11.3 -21.38 -68.85

Gisela Paulsen Ownership Network

Ownership Network List of Gisela Paulsen

No Data

Ownership Network Relation of Gisela Paulsen

Gisela Paulsen Owned Company Details

What does Exact Sciences Corp do?

Exact Sciences Corporation, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test, a non-invasive stool-based DNA test, is a pre-cancer screening test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a genetic-based treatment selection test for breast, prostate, and colon cancers. With the acquisitions of Base Genomics and Thrive Earlier Detection, Exact is building a multi-cancer early screening test to detect over 14 cancers, a test that would be one of the earliest entrants in multi-cancer liquid biopsy cancer screening.

Who are the key executives at Exact Sciences Corp?

Gisela Paulsen is the Gen Mgr & Precision Oncology of Exact Sciences Corp. Other key executives at Exact Sciences Corp include General Counsel James Herriott , Gen. Mgr. & Precision Oncology Brian Baranick , and Chief Commercial Officer Everett Cunningham .

Exact Sciences Corp (EXAS) Insider Trades Summary

Over the past 18 months, Gisela Paulsen made no insider transaction in Exact Sciences Corp (EXAS). Other recent insider transactions involving Exact Sciences Corp (EXAS) include a net sale of 23,062 shares made by Sarah Condella , a net sale of 112,268 shares made by Kevin T Conroy , and a net sale of 17,195 shares made by Jacob A Orville .

In summary, during the past 3 months, insiders sold 59,388 shares of Exact Sciences Corp (EXAS) in total and bought 0 shares, with a net sale of 59,388 shares. During the past 18 months, 210,480 shares of Exact Sciences Corp (EXAS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 210,480 shares.

Exact Sciences Corp (EXAS)'s detailed insider trading history can be found in Insider Trading Tracker table.


Exact Sciences Corp Insider Transactions

Total 0
Shares Owned
Trade Price($)
Trade Percentage(%)
Price change since trade(%)
Share ownership details
Filing Date
Total 0

Gisela Paulsen Mailing Address

Above is the net worth, insider trading, and ownership report for Gisela Paulsen. You might contact Gisela Paulsen via mailing address: 5505 Endeavor Lane, Madison Wi 53719.